carbon monoxide has been researched along with Factor XIII Deficiency in 2 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Factor XIII Deficiency: A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor (FSF) that prevents blood clot formation and results in a clinical hemorrhagic diathesis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, VG | 2 |
| Kirklin, JK | 2 |
| George, JF | 2 |
| Messinger, JD | 1 |
2 other studies available for carbon monoxide and Factor XIII Deficiency
| Article | Year |
|---|---|
Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
Topics: Blood Coagulation; Carbon Monoxide; Diatomaceous Earth; Drug Evaluation, Preclinical; Factor XIII De | 2009 |
Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and Factor XIII deficient plasmas.
Topics: Biopolymers; Blood Coagulation; Carbon Monoxide; Drug Resistance; Factor XIII Deficiency; Fibrin; Fi | 2010 |